102 related articles for article (PubMed ID: 26215863)
1. Matching Kidneys and Urines: Establishing Noninvasive Surrogates of Intrarenal Events in Primary Glomerulonephritis.
Reich HN; Sabelnykova VY; Boutros PC
Semin Nephrol; 2015 May; 35(3):256-65. PubMed ID: 26215863
[TBL] [Abstract][Full Text] [Related]
2. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
[TBL] [Abstract][Full Text] [Related]
3. Renal biopsy-driven molecular target identification in glomerular disease.
Lindenmeyer MT; Kretzler M
Pflugers Arch; 2017 Aug; 469(7-8):1021-1028. PubMed ID: 28664406
[TBL] [Abstract][Full Text] [Related]
4. Intrarenal fibrin deposition and its relation to prognosis in proliferative glomerulonephritis.
Davison AM; Thomson D; MacDonald MK
J Pathol; 1973 Jan; 109(1):Pxii. PubMed ID: 4578323
[No Abstract] [Full Text] [Related]
5. Urinary excretion of soluble tumour necrosis factor receptor 1 as a marker of increased risk of progressive kidney function deterioration in patients with primary chronic glomerulonephritis.
Idasiak-Piechocka I; Oko A; Pawliczak E; Kaczmarek E; Czekalski S
Nephrol Dial Transplant; 2010 Dec; 25(12):3948-56. PubMed ID: 20525973
[TBL] [Abstract][Full Text] [Related]
6. Kidney biopsy results versus clinical parameters on mortality and ESRD progression in 2687 patients with glomerulonephritis.
Haider DG; Masghati S; Goliasch G; Mouhieddine M; Wolzt M; Fuhrmann V; Hörl WH; Kaider A; Soleiman A
Eur J Clin Invest; 2014 Jun; 44(6):578-86. PubMed ID: 24749685
[TBL] [Abstract][Full Text] [Related]
7. [Clinico-morphologic analysis of compensatory and adaptive processes of the kidneys in chronic glomerulonephritis].
Zufarov AK
Ter Arkh; 1989; 61(6):73-5. PubMed ID: 2799721
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of expression signatures in glomerular disease.
Tryggvason SH; Guo J; Nukui M; Norlin J; Haraldsson B; Jörnvall H; Tryggvason K; He L
Kidney Int; 2013 Sep; 84(3):591-9. PubMed ID: 23783239
[TBL] [Abstract][Full Text] [Related]
9. [Serum and urinary interleukin-6 levels in patients with primary glomerulonephritis].
Hrvacević R; Topalov D; Stojanović R; Lilić D; Dimitrijević J; Maksić Dj; Marić M
Srp Arh Celok Lek; 1996; 124 Suppl 1():40-2. PubMed ID: 9102925
[TBL] [Abstract][Full Text] [Related]
10. [Transamidinase activity of blood serum and urine and puncture biopsy of the kidney in children with diffuse glomerulonephritis].
Krasin'kova GV
Vopr Okhr Materin Det; 1975 Apr; 20(4):14-6. PubMed ID: 1154678
[No Abstract] [Full Text] [Related]
11. Renal biopsy in chronic kidney disease: lessons from a large Italian registry.
Zaza G; Bernich P; Lupo A;
Am J Nephrol; 2013; 37(3):255-63. PubMed ID: 23485642
[TBL] [Abstract][Full Text] [Related]
12. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis.
Segerer S; Banas B; Wörnle M; Schmid H; Cohen CD; Kretzler M; Mack M; Kiss E; Nelson PJ; Schlöndorff D; Gröne HJ
Am J Pathol; 2004 Feb; 164(2):635-49. PubMed ID: 14742268
[TBL] [Abstract][Full Text] [Related]
13. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis.
Arakawa T; Masaki T; Hirai T; Doi S; Kuratsune M; Arihiro K; Kohno N; Yorioka N
Nephrol Dial Transplant; 2008 Nov; 23(11):3418-26. PubMed ID: 18556750
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
[TBL] [Abstract][Full Text] [Related]
15. Glomerular capillary and endothelial cell injury is associated with the formation of necrotizing and crescentic lesions in crescentic glomerulonephritis.
Fujita E; Nagahama K; Shimizu A; Aoki M; Higo S; Yasuda F; Mii A; Fukui M; Kaneko T; Tsuruoka S
J Nippon Med Sch; 2015; 82(1):27-35. PubMed ID: 25797872
[TBL] [Abstract][Full Text] [Related]
16. Intrarenal localization of interleukin-1 beta mRNA in crescentic glomerulonephritis.
Jenkins DA; Wojtacha DR; Swan P; Fleming S; Cumming AD
Nephrol Dial Transplant; 1994; 9(9):1228-33. PubMed ID: 7816281
[TBL] [Abstract][Full Text] [Related]
17. [Molecular factors of angiogenesis in renal tissue of patients with chronic glomerulonephritis: association with nephrosclerosis and anemia].
Shvetsov MIu; Ivanov AA; Kuznetsova AV; Popova OP; Rameeva AS
Ter Arkh; 2009; 81(8):14-9. PubMed ID: 19799194
[TBL] [Abstract][Full Text] [Related]
18. Biomarker discovery in glomerular diseases using urinary proteomics.
Thongboonkerd V
Proteomics Clin Appl; 2008 Oct; 2(10-11):1413-21. PubMed ID: 21136790
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis.
Turner CM; Tam FW; Lai PC; Tarzi RM; Burnstock G; Pusey CD; Cook HT; Unwin RJ
Nephrol Dial Transplant; 2007 Feb; 22(2):386-95. PubMed ID: 17040997
[TBL] [Abstract][Full Text] [Related]
20. L-FABP: A novel biomarker of kidney disease.
Xu Y; Xie Y; Shao X; Ni Z; Mou S
Clin Chim Acta; 2015 May; 445():85-90. PubMed ID: 25797895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
